CD33, an immunomodulatory receptor, is expressed at high levels on neutrophils and low levels on microglia and has divergent roles in regulating phagocytosis responsible for AD pathology (Griciuc et al., 2013; Estus et al., 2019). Here, CD33 is linked to Alzheimer disease.